Aya Nakaya¹, Hirokazu Tanaka^2,20, Hideo Yagi^3,20, Kensuke Ohta^4,20, Hirohiko Shibayama^5,20, Junya Kanda^6,20, Maki Shindo^6,20, Yuji Shimura^7,20, Satoru Kosugi^8,20, Toru Kida^8,20, Hitomi Kaneko^9,20, Kazunori Imada^9,20, Takahiro Karasuno^10,20, Mitsuhiro Matsuda^11,20, Masato Iida^12,20, Yoko Adachi^13,20, Shin-Ichi Fuchida^14,20, Nobuhiko Uoshima^15,20, Hitoji Uchiyama^16,20, Ryoichi Takahashi^17,20, Toshimitsu Matsui^18,20, Katsuya Wada^19,20, Miki Kiyota^19,20, Chihiro Shimazaki^14,20, Masayuki Hino²⁰, Junya Kuroda^7,20, Yuzuru Kanakura^5,20, Akifumi Takaori-Kondo^6,20, Shosaku Nomura^1,20, Itaru Matsumura^2,20 (1.First Department of Internal Medicine, Kansai Medical University, 2.Department of Hematology and Rheumatology, Kindai University, Osaka, Japan, 3.Nara Prefecture General Medical Center, Nara, Japan, 4.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, japan, 5.Department of Hematology and Oncology, Osaka University, Osaka, Japan, 6.Dpt. of Hematology and Oncology, Kyoto Univ., Kyoto, Japan, 7.Kyoto Prefectural University of Medicine, Kyoto, Japan, 8.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 9.Department of Hematology,Japanese Red Cross Osaka Hospital, Osaka, Japan, 10.Department of Hematology, Rinku General Medical Center, Osaka, Japan, 11.Department of Hematology, PL General Hospital, Osaka, Japan, 12.Kawasaki Hospital Internal Medicine, Hyogo, Japan, 13.JCHO Kobe Central Hospital, Department of Internal Medicine, Hyogo, Japan, 14.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 15.Department of Hematology,Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 16.JRC Kyoto Daiichi Hospital, Kyoto, Japan, 17.Department of Hematology, Omihachiman Community Medical Center, Shiga, Japan, 18.Department of Hematology, NIshiwaki Municipal Hospital, Hyogo, Japan, 19.Department of Hematology, Matsushita Memorial Hospital, Osaka, Japan, 20.Kansai Myeloma Forum, Osaka, Japan)

Akinori Wada¹, Motoki Eguchi¹, Kotaro Arita¹, Jun Murakami¹, Toshiro Sugiyama¹, Tsutomu Sato¹, Yuki Yamazaki², Shinnichi Hayashi³, Hiroyuki Takamatsu⁴ (1.Hematology, Toyama University Hospital, Toyama, Japan, 2.Gynecology, Takaoka City Hospital, Takaoka, Japan, 3.Clinical pathology, Takaoka City Hospital, Takaoka, Japan, 4.Hematology, Kanazawa University Hospital, Kanazawa, Japan)

Kayo Toishigawa¹, Hisao Nagoshi¹, Keita Fujino¹, Taro Edahiro¹, Takahiko Miyama¹, Takehiko Morioka¹, Takakazu Kawase², Keichiro Mihara¹, Noriyasu Fukushima², Tatsuo Ichinohe² (1.Hematol., Hiroshima Univ. Hosp., Hiroshima, Japan, 2.Hematol/Oncol., RIRBM, Hiroshima Univ., Hiroshima, Japan)

Ayumi Saito, Daisuke Miura, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Hematology, Kameda Medical Center, Chiba, Japan)

Shinichiro Tsunoda¹, Kazutaka Yamamoto², Hidetoshi Ujiie², Yuko Karasuno², Shuhei Kida², Kumi Shibata², Hiroyuki Sugahara² (1.Division of Immunology & Rheumatology, Department of Internal Medicine, Sumitomo Hospital, 2.Division of Hematology, Department of Internal Medicine, Sumitomo Hospital)

Yukako Teramoto, Masaki Iwasa, Ai Asai, Aya Fujishiro, Rie Nishimura, Masahiro Kawahara, Hitoshi Minamiguchi, Katsuyuki Kito, Akira Andoh (Hematol., Shiga Univ. of Med. Sci., Shiga, Japan)